Acumen Pharmaceuticals, Inc.

ABOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G Apr 7, 2026
EFFECT Apr 1, 2026
424B3 Apr 1, 2026 424B3
CORRESP Mar 30, 2026
UPLOAD Mar 30, 2026
S-3 Mar 26, 2026 S-3
S-8 Mar 26, 2026 S-8
10-K Mar 26, 2026 10-K
8-K Mar 26, 2026 8-K
4 Mar 18, 2026
SCHEDULE 13D/A Mar 17, 2026
8-K Mar 16, 2026 8-K
4 Mar 10, 2026 FORM 4
144 Mar 6, 2026
4 Mar 3, 2026 FORM 4
144 Feb 27, 2026
4 Jan 28, 2026 FORM 4
144 Jan 28, 2026
144 Jan 26, 2026
4 Jan 23, 2026 FORM 4
4 Jan 23, 2026 FORM 4
4 Jan 23, 2026 FORM 4
4 Jan 23, 2026 FORM 4
4 Jan 23, 2026 FORM 4
144 Jan 23, 2026
← Newer Page 2 of 15 · 358 filings Older →